Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market BioTech June 25, 2025 Technology Co-Developed by the U.S. Department of Veteran Affairs and Emory University Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the…
